Active Motive

Active Motif, Inc. is pleased to announce the availability of AKS v2.1. The new version still allows users to uncover bioentity relationships that exist in over 8 million PubMed abstracts, but it now includes chemical information for millions of compounds and links to external databases such as PubChem. Additional functionality includes new internet subscription access, query alerts via e-mail, new export options, additional search options, new trend analyses, and enhanced graphical information.

more info: http://www.activemotif.com/company/news/2007-09-17

Bioalma, Madrid, Spain

Bioalma (Madrid, Spain), announce that Siena Biotech S.p.A. (http://www.sienabiotech.com) has extended its license of AKS2 (almaKnowledgeServer™). AKS2 has provided Siena Biotech a way to rapidly explore not only disease, gene, and compound topics found in published literature but also drug, symptom, and biomedical relationships as well. Siena Biotech will use the knowledge mining system to explore results obtained with their comprehensive proteomics platform.

“The newly designed AKS2 will support our disease-based research.” Dr. Georg C. Terstappen, Vice President Discovery Research at Siena Biotech S.p.A., explained, “We have been working with Bioalma for some time now and the new AKS2 will help us extracting knowledge from the data generated in our high-throughput experiments”

Juan Carlos del Castillo, CEO of Bioalma, commented, “Our current AKS2 customers continue to see the value of text mining and how it helps their drug discovery efforts. I am happy Siena Biotech has selected AKS2 as part of their scientific knowledge provider.

more info: http://www.bioalma.com/aks2

bioalma

Bioalma will be one of the speakers at the ICIC meeting in Nimes (22-25 October 2006).

more info: http://www.infonortics.com/chemical/

Active Motif, bioalma

Active Motif, Inc. is pleased to announce the launch of its latest text mining system, AKS2 (almaKnowledgeServer™) from bioalma. The newly-designed interface of AKS2 enables rapid exploration of not only disease, gene, and compound topics found in published literature but also drug, symptom, and
biomedical relationships as well. AKS2 automatically analyzes all published abstracts from Medline, classifies all relevant terms into categories, and applies sophisticated text mining techniques based on contextual information. This opens the door to exploring biomedical literature in a whole new way

more info: http://www.marketwire.com/mw/release_html_b1?release_id=163754

American Technology Laboratory, Issue Feb 2006

A very interesting review on Text Mining applied to biomedical literature and the challenges to overcome. It provides insight on
how annotation ambiguities can be dealt, the importance of extracting keywords to classify documents and sentences, and how
this technology allows to explore and discover new relationships when used along with advanced visualization packages.

more info: http://www.americantechnologylaboratory.com

internal release

Bioalma and ActiveMotif will jointly attend these two events. You are very welcomed to meet us at Bio-IT (Boston, 3rd-5th April) and Bio-2006 (Chicago, 9th-12th April; Spanish Pavillion-711). To schedule a meeting please contact: Arantxa Sanz, asanz@bioalma.com; mob: +34 653 837 985

more info: https://aks.bioalma.com

October edition - Scientific Computing World

The agreement among bioalma and Time Logic to integrate AKS into their CodeQuest pipeline is highlighted in SCW october issue

more info: http://www.scientific-computing.com/news_oct05.html#7

Deloitte's Technology Fast 50 Program

Active Motif, develops accelerated hardware & software for bioinformatics and integrated the bioalma product AKS to enhance scientific knowledge. Active Motif has been named to Deloitte's prestigious Technology Fast 50 Program for San Diego one of the nation's leading professional services firms. Rankings are based on the percentage revenue growth over five years from 2000-2004.

more info: http://www.activemotif.com/company/news/2005-09-22

Reinhard Scneider, EMBL Group Leader & Juan Carlos del Castillo, bioalma CEO

The basic terms of the agreement allow researchers based at EMBL as well as those based at outstations located in Germany, United Kingdom, Italy and France to have access to the system.

The aim of Reinhard Schneiders group at the EMBL is to capture and centralize the knowledge generated by the scientists in the several divisions, and to organize that knowledge in such a way that it is easily mined, browsed and navigated.

By providing access to all scientists in the organization, it will foster collaboration between researchers in different cross functional groups.bioalma and Reinhard Schneiders group will overcome current limitations of text mining algorithms to detect information related to chemicals and drugs from scientific text and to integrate this information in the databases used by researchers at the EMBL.

more info: http://www.marketwire.com/mw/release_html_b1?release_id=094487

Joseph Fernandez, Active Motif CEO & Juan Carlos del Castillo, bioalma CEO

CodeQuest™ discovery workstation will include AKS as an add-on module combining visual bioinformatics pipeline development, computational processing, and intuitive scientific literature mining. Thanks to this the agreement CodeQuest will offer rapid exploration of text information, biomedical entities, etc.

CodeQuest™ is a pipeline building system with drag-and-drop simplicity that makes powerful text mining technology available to a wide range of life-science specialists.

more info: http://www.marketwire.com/mw/release_html_b1?release_id=089299